Search
for
Sort by
Research 841–870 of 1000+
- Comparative Study Between 2% Minoxidil Topical Spray vs. Intradermal Injection (Mesotherapy) for Treatment of Androgenetic Alopecia in Female Patients: A Controlled, 4-month Randomized Trial
- Preclinical efficacy and safety evaluation of a topical mesenchymal stem cell derived conditioned media gel for oral mucositis management
- 201 Analysis of mice skin distribution using MALDI-MSI after subcutaneous injections of a new potent novel inhibitor of human hair growth, FOL-005
- CASE REPORT: DERMATITIS IN A MIX DOG WITH TOPICAL CANDLENUT OIL THERAPY AND FINDING OF ANCYLOSTOMA SPP. INFECTION
- Dermatological drugs, topical agents, and cosmetics
- The Mesenchymal Niche of the Hair Follicle Induces Regeneration by Releasing Primed Progenitors from Inhibitory Effects of Quiescent Stem Cells
- Androgens and acne: perspectives on clascoterone, the first topical androgen receptor antagonist
- 910 Transepidermal UV radiation of human scalp skin induces distinctive hair follicle damage, which is mitigated by topical caffeine treatment
- Study on the mechanism of cadmium chloride pollution accelerating skin tissue metabolism disorder, aging and inhibiting hair regeneration
- The effect of experimental hypothyroidism on the skin of adult male albino rats and the therapeutic role of topical triiodothyronine
- Efficacy and safety of topical rosuvastatin & melatonin vs. placebo in patients with mild to moderate plaque psoriasis: A preliminary randomized double‐blinded clinical trial
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Opportunities for topical antimicrobial therapy: permeation of canine skin by fusidic acid
- Successful treatment of epidermal growth factor receptor inhibitor–induced alopecia with doxycycline
- BH20 An unintended sequela of hair regrowth: severe Janus kinase inhibitor-associated acneiform eruption in alopecia areata
- Is the Safety of Finasteride Correlated With Its Route of Administration: Topical Versus Oral? A Pharmacovigilance Study With Data From the United States Food and Drug Administration Adverse Event Reporting System
- Use of Topical Finasteride Vs Systemic Finasteride in Male Pattern Baldness
- The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm
- Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis
- Tofacitinib for the treatment of alopecia areata in preadolescent children
- A Case of Topical Ruxolitinib Treatment Failure in Alopecia Areata
- Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents
- Frontal Fibrosing Alopecia: A Retrospective Analysis of 72 Patients from a German Academic Center
- Impact of Previous Alopecia Areata Treatment on Efficacy Responses up to Week 48 Following Ritlecitinib Treatment: A Post Hoc Analysis
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Pediatric and Adolescent Alopecia Areata Treated with JAK Inhibitors: Balancing Efficacy and Safety Across Clinical Trials
- Efficacy and Safety of Topical Tofacitinib for the Treatment of Alopecia Areata
- A Phase 1 Study to Investigate the Effects of Cortexolone 17α‐Propionate, Also Known as Clascoterone, on the QT Interval Using the Meal Effect to Demonstrate ECG Assay Sensitivity
- Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date
- Topical finasteride in the treatment of androgenic alopecia. Preliminary evaluations after a 16-month therapy course